• レポートコード:QYR2104Z1499 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、93ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療機器 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、コンパニオン診断のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(アッセイキット、試薬)、用途別市場規模(製薬・バイオ医薬品会社、研究所、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・コンパニオン診断の市場動向 ・企業の競争状況、市場シェア ・コンパニオン診断の種類別市場規模(アッセイキット、試薬) ・コンパニオン診断の用途別市場規模(製薬・バイオ医薬品会社、研究所、その他) ・コンパニオン診断の北米市場規模2016-2027(アメリカ、カナダ) ・コンパニオン診断のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・コンパニオン診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・コンパニオン診断の中南米市場規模2016-2027(メキシコ、ブラジル) ・コンパニオン診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Abbott Laboratories、Agilent Technologies、Danaher、Illumina、Myriad Genetics、Qiagen、Roche、Thermo Fisher Scientific、Sysmex、Novartis) ・結論 |
A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
Market Analysis and Insights: Global Companion Diagnostic Market
The global Companion Diagnostic market size is projected to reach US$ 32340 million by 2026, from US$ 8820 million in 2019, at a CAGR of 20.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic market.
Global Companion Diagnostic Scope and Market Size
Companion Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Assay Kits
Reagents
Segment by Application
Pharmaceutical & Biopharmaceutical Companies
Laboratories
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Agilent Technologies
Danaher
Illumina
Myriad Genetics
Qiagen
Roche
Thermo Fisher Scientific
Sysmex
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Assay Kits
1.2.3 Reagents
1.3 Market by Application
1.3.1 Global Companion Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Laboratories
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Market Perspective (2016-2027)
2.2 Companion Diagnostic Growth Trends by Regions
2.2.1 Companion Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Companion Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Companion Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Companion Diagnostic Industry Dynamic
2.3.1 Companion Diagnostic Market Trends
2.3.2 Companion Diagnostic Market Drivers
2.3.3 Companion Diagnostic Market Challenges
2.3.4 Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Players by Revenue
3.1.1 Global Top Companion Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Revenue
3.4 Global Companion Diagnostic Market Concentration Ratio
3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2020
3.5 Companion Diagnostic Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Breakdown Data by Type
4.1 Global Companion Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Companion Diagnostic Forecasted Market Size by Type (2022-2027)
5 Companion Diagnostic Breakdown Data by Application
5.1 Global Companion Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Companion Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Companion Diagnostic Market Size (2016-2027)
6.2 North America Companion Diagnostic Market Size by Type
6.2.1 North America Companion Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Companion Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Companion Diagnostic Market Size by Type (2016-2027)
6.3 North America Companion Diagnostic Market Size by Application
6.3.1 North America Companion Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Companion Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Companion Diagnostic Market Size by Application (2016-2027)
6.4 North America Companion Diagnostic Market Size by Country
6.4.1 North America Companion Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Companion Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Companion Diagnostic Market Size (2016-2027)
7.2 Europe Companion Diagnostic Market Size by Type
7.2.1 Europe Companion Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Companion Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Companion Diagnostic Market Size by Type (2016-2027)
7.3 Europe Companion Diagnostic Market Size by Application
7.3.1 Europe Companion Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Companion Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Companion Diagnostic Market Size by Application (2016-2027)
7.4 Europe Companion Diagnostic Market Size by Country
7.4.1 Europe Companion Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Companion Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Companion Diagnostic Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Companion Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Companion Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Companion Diagnostic Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Companion Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Companion Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Companion Diagnostic Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Companion Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Market Size (2016-2027)
9.2 Latin America Companion Diagnostic Market Size by Type
9.2.1 Latin America Companion Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Companion Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Companion Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Companion Diagnostic Market Size by Application
9.3.1 Latin America Companion Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Companion Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Companion Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Companion Diagnostic Market Size by Country
9.4.1 Latin America Companion Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Companion Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Companion Diagnostic Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Companion Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Companion Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Companion Diagnostic Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Companion Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Companion Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Companion Diagnostic Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Companion Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Companion Diagnostic Introduction
11.1.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Companion Diagnostic Introduction
11.2.4 Agilent Technologies Revenue in Companion Diagnostic Business (2016-2021)
11.2.5 Agilent Technologies Recent Development
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher Companion Diagnostic Introduction
11.3.4 Danaher Revenue in Companion Diagnostic Business (2016-2021)
11.3.5 Danaher Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Companion Diagnostic Introduction
11.4.4 Illumina Revenue in Companion Diagnostic Business (2016-2021)
11.4.5 Illumina Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Details
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Companion Diagnostic Introduction
11.5.4 Myriad Genetics Revenue in Companion Diagnostic Business (2016-2021)
11.5.5 Myriad Genetics Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Companion Diagnostic Introduction
11.6.4 Qiagen Revenue in Companion Diagnostic Business (2016-2021)
11.6.5 Qiagen Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Companion Diagnostic Introduction
11.7.4 Roche Revenue in Companion Diagnostic Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Companion Diagnostic Introduction
11.8.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2016-2021)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Sysmex
11.9.1 Sysmex Company Details
11.9.2 Sysmex Business Overview
11.9.3 Sysmex Companion Diagnostic Introduction
11.9.4 Sysmex Revenue in Companion Diagnostic Business (2016-2021)
11.9.5 Sysmex Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Companion Diagnostic Introduction
11.10.4 Novartis Revenue in Companion Diagnostic Business (2016-2021)
11.10.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Assay Kits
Table 3. Key Players of Reagents
Table 4. Global Companion Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Companion Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Companion Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Companion Diagnostic Market Share by Regions (2016-2021)
Table 8. Global Companion Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Companion Diagnostic Market Share by Regions (2022-2027)
Table 10. Companion Diagnostic Market Trends
Table 11. Companion Diagnostic Market Drivers
Table 12. Companion Diagnostic Market Challenges
Table 13. Companion Diagnostic Market Restraints
Table 14. Global Companion Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Companion Diagnostic Market Share by Players (2016-2021)
Table 16. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic as of 2020)
Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Diagnostic Product Solution and Service
Table 21. Date of Enter into Companion Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Companion Diagnostic Revenue Market Share by Type (2016-2021)
Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Companion Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Companion Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Companion Diagnostic Revenue Market Share by Application (2016-2021)
Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Companion Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Companion Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Companion Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Companion Diagnostic Product
Table 64. Abbott Laboratories Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Agilent Technologies Company Details
Table 67. Agilent Technologies Business Overview
Table 68. Agilent Technologies Companion Diagnostic Product
Table 69. Agilent Technologies Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 70. Agilent Technologies Recent Development
Table 71. Danaher Company Details
Table 72. Danaher Business Overview
Table 73. Danaher Companion Diagnostic Product
Table 74. Danaher Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 75. Danaher Recent Development
Table 76. Illumina Company Details
Table 77. Illumina Business Overview
Table 78. Illumina Companion Diagnostic Product
Table 79. Illumina Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 80. Illumina Recent Development
Table 81. Myriad Genetics Company Details
Table 82. Myriad Genetics Business Overview
Table 83. Myriad Genetics Companion Diagnostic Product
Table 84. Myriad Genetics Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 85. Myriad Genetics Recent Development
Table 86. Qiagen Company Details
Table 87. Qiagen Business Overview
Table 88. Qiagen Companion Diagnostic Product
Table 89. Qiagen Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 90. Qiagen Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Companion Diagnostic Product
Table 94. Roche Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Thermo Fisher Scientific Company Details
Table 97. Thermo Fisher Scientific Business Overview
Table 98. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 99. Thermo Fisher Scientific Recent Development
Table 100. Sysmex Company Details
Table 101. Sysmex Business Overview
Table 102. Sysmex Companion Diagnostic Product
Table 103. Sysmex Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 104. Sysmex Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Companion Diagnostic Product
Table 108. Novartis Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
Table 109. Novartis Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Assay Kits Features
Figure 3. Reagents Features
Figure 4. Global Companion Diagnostic Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical & Biopharmaceutical Companies Case Studies
Figure 6. Laboratories Case Studies
Figure 7. Other Case Studies
Figure 8. Companion Diagnostic Report Years Considered
Figure 9. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Companion Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Companion Diagnostic Market Share by Regions: 2020 VS 2027
Figure 12. Global Companion Diagnostic Market Share by Regions (2022-2027)
Figure 13. Global Companion Diagnostic Market Share by Players in 2020
Figure 14. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2020
Figure 16. Global Companion Diagnostic Revenue Market Share by Type (2016-2021)
Figure 17. Global Companion Diagnostic Revenue Market Share by Type (2022-2027)
Figure 18. North America Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Companion Diagnostic Market Share by Type (2016-2027)
Figure 20. North America Companion Diagnostic Market Share by Application (2016-2027)
Figure 21. North America Companion Diagnostic Market Share by Country (2016-2027)
Figure 22. United States Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Companion Diagnostic Market Share by Type (2016-2027)
Figure 26. Europe Companion Diagnostic Market Share by Application (2016-2027)
Figure 27. Europe Companion Diagnostic Market Share by Country (2016-2027)
Figure 28. Germany Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Companion Diagnostic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Companion Diagnostic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Companion Diagnostic Market Share by Region (2016-2027)
Figure 38. China Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Companion Diagnostic Market Share by Type (2016-2027)
Figure 46. Latin America Companion Diagnostic Market Share by Application (2016-2027)
Figure 47. Latin America Companion Diagnostic Market Share by Country (2016-2027)
Figure 48. Mexico Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Companion Diagnostic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Companion Diagnostic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Companion Diagnostic Market Share by Country (2016-2027)
Figure 54. Turkey Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 58. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 59. Danaher Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 60. Illumina Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 61. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 62. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 65. Sysmex Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed